Vasculitis leucocitoclástica tras la vacunación en una paciente con enfermedad inflamatoria intestinal

  1. María Fernández Prada 1
  2. Paula Alonso Penanes 2
  3. Patricia Morales del Burgo 3
  4. I. Pérez Martínez 3
  5. María Clara Villa del Amo 3
  1. 1 Hospital Vital Álvarez Buylla. Mieres, Asturias
  2. 2 Universidad de Oviedo. Oviedo, Asturias
  3. 3 Hospital Universitario Central de Asturias. Oviedo, Asturias
Show affiliations +
Journal:
Revista Española de Enfermedades Digestivas

ISSN: 2340-416,  1130-0108

Year of publication: 2019

Volume: 111

Issue: 5

Pages: 402-404

Type: Article

DOI: 10.17235/REED.2019.5963/2018 DIALNET GOOGLE SCHOLAR

More publications in: Revista Española de Enfermedades Digestivas

Abstract

Patients with inflammatory bowel disease are likely to receive immunomodulation treatment and therefore, should be properly vaccinated. Despite their proven safety, vaccines are not exempt from adverse reactions. The clinical case was a young female with ulcerative colitis under mesalazine treatment, who developed leukocytoclastic vasculitis following vaccination for pneumococci, varicella and hepatitis A. This adverse reaction after the previously mentioned vaccines is barely described in the literature and has never been reported in a patient with an underlying condition.

Data source: Dialnet